PSNL
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Personalis secures fourth Medicare coverage decision for NeXT Personal, expanding breast cancer monitoring coverageMay 20, 2026
- Personalis received Medicare coverage for NeXT Personal immunotherapy monitoring across late-stage solid tumorsMay 13, 2026
- Personalis announces new data from a landmark lung cancer trial utilizing ultrasensitive MRD testingOct 17, 2025
- CATE clinical trial launched to demonstrate clinical utility of ctDNA-guided treatment in breast cancer using ultrasensitive NeXT personal testSep 11, 2025
- Personalis announces new data from landmark neoadjuvant lung cancer trial showing superiority of ultra-sensitive, tumor-informed MRD testingSep 4, 2025